Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €54.91 EUR
Change Today -0.42 / -0.76%
Volume 0.0
As of 3:12 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

catamaran corp (IA0) Snapshot

Open
€55.03
Previous Close
€55.33
Day High
€55.73
Day Low
€54.48
52 Week High
04/14/15 - €56.69
52 Week Low
04/29/14 - €27.72
Market Cap
11.4B
Average Volume 10 Days
28.4
EPS TTM
--
Shares Outstanding
207.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CATAMARAN CORP (IA0)

catamaran corp (IA0) Related Businessweek News

No Related Businessweek News Found

catamaran corp (IA0) Details

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments, PBM and HCIT. The PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail and specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. It owns and operates a network of mail and specialty pharmacies. The HCIT solutions include RxCLAIM, an online transaction processing system to provide adjudication of third-party prescription drug claims at the point of service, including claims management and review, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider, and drug details. It also provides RxBUILDER, a Web-based interface for formulary creation and maintenance; RxPORTAL, which allows customers to interact with the patient’s formulary and drug history; and RxAUTH, a prior authorization management solution. In addition, the company offers RxMAX, a rebate management system for assisting health plans in managing their relationships with pharmaceutical manufacturers; Zynchros, which provides a suite of formulary management tools; and RxTRACK, a data warehouse and analysis system. It serves various organizations in the pharmaceutical supply chain, such as federal, provincial, state, and local governments; unions; corporations; pharmacy benefit managers; managed care organizations; retail pharmacy chains; and other healthcare intermediaries. The company was formerly known as SXC Health Solutions Corp. and changed its name to Catamaran Corporation in July 2012. Catamaran Corporation was founded in 1993 and is headquartered in Schaumburg, Illinois.

Founded in 1993

catamaran corp (IA0) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $425.0K
Executive Vice President of Operations
Total Annual Compensation: $700.0K
Executive Vice President of Pharmacy Operatio...
Total Annual Compensation: $475.0K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

catamaran corp (IA0) Key Developments

Catamaran Corporation Presents at Barclays Global Healthcare Conference, Mar-10-2015 03:20 PM

Catamaran Corporation Presents at Barclays Global Healthcare Conference, Mar-10-2015 03:20 PM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Michael H. Shapiro, Chief Financial Officer and Senior Vice President.

Catamaran Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

Catamaran Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company's revenue was $5,739,890,000 compared to $4,528,800,000 a year ago. Operating income was $169,106,000 compared to $126,110,000 a year ago. Income before income taxes was $152,899,000 compared to $115,457,000 a year ago. Net income was $113,824,000 compared to $87,670,000 a year ago. Net income attributable to the Company was $100,448,000 compared to $74,403,000 a year ago. Diluted earnings per share attributable to the company was $0.48 compared to $0.36 a year ago. Net cash provided by operating activities was $163,045,000 compared to $139,542,000 a year ago. Purchases of property and equipment was $31,869,000 compared to $35,571,000 a year ago. EBITDA was $221,818,000 compared to $181,969,000 a year ago. Non-GAAP net income attributable to the Company was $138,423,000 compared to $116,773,000 a year ago. Non-GAAP diluted earnings per share attributable to the company was $0.67 compared to $0.56 a year ago. For the year, the company's revenue was $21,581,890,000 compared to $14,780,094,000 a year ago. Operating income was $568,996,000 compared to $443,768,000 a year ago. Income before income taxes was $507,908,000 compared to $402,142,000 a year ago. Net income was $373,722,000 compared to $298,739,000 a year ago. Net income attributable to the Company was $317,293,000 compared to $262,170,000 a year ago. Diluted Earnings per share attributable to the Company was $1.53 compared to $1.27 a year ago. Net cash provided by operating activities was $590,181,000 compared to $475,421,000 a year ago. Purchases of property and equipment was $78,078,000 compared to $128,842,000 a year ago. EBITDA was $786,876,000 compared to $651,096,000 a year ago. Non-GAAP net income attributable to the Company was $474,223,000 compared to $413,142,000 a year ago. Non-GAAP diluted earnings per share attributable to the company was $2.28 compared to $2.00 a year ago. Net income and EPS attributable to the Company increased during both periods due to increased revenue as a result of new customer implementations and additional income generated as a result of the Restat acquisition. These positive impacts to net income attributable to the Company were offset by an increase in operating expenses as discussed above, plus an increase in interest expense. The EBITDA growth was primarily due to increased net income attributable to the Company as a result of increased revenue, as noted previously. This was partially offset by increased costs incurred to support the Company's business growth. Cash from operating activities increased during both periods mainly due to an increase in net income. For the year 2015, the company has set the full year financial targets, which do not include any impact from the proposed acquisition of Healthcare Solutions. The company expects revenue of $23.5 billion to $24.5 billion, EBITDA of $905 million to $930 million, GAAP EPS (fully-diluted) of $1.77 to $1.92 and adjusted EPS (fully-diluted) of $2.45 to $2.60 (excluding all amortization of intangible assets). Depreciation in the range of $65 million to $70 million. Tax rate to increase to 30% to 32%, which is more consistent with historical averages. The company also expects to generate more than $600 million in cash flow from operations and expect CapEx to be relatively flat to 2014.

Catamaran Seeks Acquisitions

Catamaran Corporation (TSX:CCT) continues to manage robust pipeline of acquisition opportunities that complement core competencies and strengthen market position in important segments.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IA0:GR €54.91 EUR -0.42

IA0 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anthem Inc $152.48 USD -2.45
BioScrip Inc $5.26 USD +0.02
Cigna Corp $131.13 USD -1.67
Express Scripts Holding Co $85.55 USD -0.82
Walgreens Boots Alliance Inc $86.96 USD -2.56
View Industry Companies
 

Industry Analysis

IA0

Industry Average

Valuation IA0 Industry Range
Price/Earnings 38.7x
Price/Sales 0.6x
Price/Book 2.3x
Price/Cash Flow 20.8x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATAMARAN CORP, please visit www.catamaranrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.